Tom Thomas
InvestorPrincipal at Newpath Partners · Therapeutics Advisory Panel, UCLA Innovation Fund at UCLA Ventures
Boston, Massachusetts
Writes $500K – $40M checks · typically $15M
Find your path to Tom
759 people in our graph can introduce you to Tom.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Eva Ho to introduce you to Tom
You →Eva · together at UCLA Ventures (2025–2026) →Tom
Ask Jamie Chen to introduce you to Tom
You →Jamie · 6 people · together at Cedars-Sinai →Tom
Ask Sam Okafor to introduce you to Tom
You →Sam · 5 people · together at Cleveland Clinic →Tom
Sign up to find every way you can get introduced to Tom
- Your email: the people you already email who know Tom
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Tom
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Tom Thomas is an investor at Newpath Partners and serves as a board director at CREATE Medicines. He has held positions at RA Capital Management focusing on oncology investments and co-founded Flagship Labs 89, where he served as head of translational biology. His background includes cancer biology research with expertise in patient-derived cell models, organoid systems, and cancer metabolomics.
Experience
- CREATE MedicinesBoard Directorcurrent2026 — present
- Cleveland ClinicExternal Advisory Councilcurrent2026 — present
- Newpath PartnersInvestor, Principalcurrent2024 — present
- UCLA Technology Development GroupTherapeutics Advisory Panel, UCLA Innovation Fundcurrent2025 — present
- Magnet BiomedicineBoard Observercurrent2024 — present
- Exo TherapeuticsBoard Directorcurrent2024 — present
- Kisbee TherapeuticsBoard Observer2024 — 2025
- Sera Medicines, LLCFounding Team2023 — 2024
- RA Capital Management, L.P.Healthcare Associate2022 — 2024Boston, Massachusetts, United States
- Prologue MedicinesFounding Team2021 — 2022
- Flagship PioneeringAssociate2020 — 2022Cambridge, Massachusetts, United States
- Flagship PioneeringFellow2020Cambridge, Massachusetts, United States
- Emmanuel College (Boston)Adjunct Faculty of Biology2018 — 2020Greater Boston Area
- Harvard Medical SchoolResearch Fellow2017 — 2020Boston, Massachusetts, United States
- Cedars-SinaiPh.D Candidate, Cancer Biology2013 — 2017
- University of California, Los AngelesResearch Associate2008 — 2011Los Angeles, California, United States
- Scripps ResearchResearch Intern2005 — 2006
Skills & more
+11 more
BiochemistryCancer ResearchCancerTumor ImmunologyStem Cell ResearchCancer Stem CellsTissue CultureMetabolismMicrosoft OfficeHealthcare InvestingCell BiologyLanguages English · Malayalam · Spanish
- Health Care Economics — Harvard Business School
- Healthcare Innovation & Commercialization — Harvard Medical School
From Tom's professional profile.
Colleagues at Newpath Partners
Frequently asked questions
- Who is Tom Thomas?
- Tom Thomas is an investor at Newpath Partners and serves as a board director at CREATE Medicines. He has held positions at RA Capital Management focusing on oncology investments and co-founded Flagship Labs 89, where he served as head of translational biology. His background includes cancer biology research with expertise in patient-derived cell models, organoid systems, and cancer metabolomics.
- Where does Tom Thomas work?
- Tom Thomas is Principal at Newpath Partners.
- What check size does Tom Thomas write?
- Tom Thomas typically writes checks of $500K – $40M.
- Where did Tom Thomas go to school?
- Tom Thomas studied at Harvard Medical School (Postdoctoral Fellowship, Molecular Pathology & Oncology); Cedars-Sinai Medical Center (Ph.D., Biomedical Science and Translational Medicine); UCLA (B.S., Physiological Sciences).
Same school
Also attended Harvard Medical School322
+ 316 more
Also attended UCLA1,020
+ 1,014 more
Shared employers
Also worked at Exo Therapeutics4
Also worked at Flagship Pioneering107
+ 101 more











































